Michigan Senate Bill SB0624

Michigan 2023-2024 Regular Session

• Introduced: 10/26/23
• Refer: 10/26/23

Caption

Health: immunizations; access to the Michigan care improvement registry; restrict and expand the registry to include the reporting of adverse events resulting from immunizing agents. Amends secs. 9206 & 9227 of 1978 PA 368 (MCL 333.9206 & 333.9227).

Impact

The bill establishes clear reporting requirements for health care providers regarding immunizations administered to minors. Providers must report each immunization to the state, except when parents or guardians submit a written objection to such reporting. This aims to create a comprehensive registry of immunization data that will significantly inform public health strategies and foster improved health outcomes among children, while attempting to balance parental rights concerning medical information about minors.

Summary

Senate Bill 624 seeks to amend the Public Health Code of Michigan (1978 PA 368) by modifying sections that govern immunizations. This legislation mandates health care providers to offer a written immunization certificate to individuals accompanying minors receiving immunizing agents. Importantly, starting January 1, 2024, these certificates will also need to include information regarding any lead poisoning tests conducted on the child. The intent is to enhance the information captured about childhood immunizations while also increasing awareness of potential lead exposure, which can be detrimental to health.

Contention

Notably, SB 624 also introduces provisions for the reporting of adverse events resulting from immunizations, effective December 31, 2024. This includes detailed requirements for health care providers to document incidents such as patient age, symptoms, and the nature of the immunizing agent linked to any adverse effects. Critics of this legislation might raise concerns about the implications of mandatory reporting on parental choice, implications for health care providers, and the potential for increased scrutiny or liability in case of adverse reactions. The debate could also encompass broader issues of public trust in vaccines and the health care system.